Reuters logo
BRIEF-Cleveland BioLabs reports Q3 ‍net loss per share, excluding minority interests, $0.11
November 14, 2017 / 1:40 PM / 4 days ago

BRIEF-Cleveland BioLabs reports Q3 ‍net loss per share, excluding minority interests, $0.11

Nov 14 (Reuters) - Cleveland BioLabs Inc

* Cleveland BioLabs reports third quarter 2017 financial results and development progress

* Q3 revenue $300,000 versus $1.1 million

* Cleveland BioLabs Inc - qtrly ‍net loss, excluding minority interests, $0.11 per share​

* Cleveland BioLabs -current cash,cash equivalents,short-term investments is expected to fund operations for at least 1 year beyond filing date of form 10-Q​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below